Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-03-06 @ 2:31 PM
Study NCT ID:
NCT04415918
Status:
UNKNOWN
Last Update Posted:
2020-06-04
First Post:
2020-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bezlotoxumab Efficacy and Tolerability in Cancer Patient
Sponsor:
The Cooper Health System
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Clostridium Difficile Infection Recurrence | View |
Keywords: